Description
The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two stages to (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-…
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $173,000,000 at start, $169,872,474 after amendment #2 (−$3,127,526).
- #02020-03-28$173,000,000
- #12022-03-30$200,000,000+$27,000,000
- #22023-11-24$169,872,474-$30,127,526
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2020-03-28(start date) | $173,000,000 | — | The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two… |
| #1 amendment | 2022-03-30 | $200,000,000 | +$27,000,000 | The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two… |
| #2 amendment | 2023-11-24 | $169,872,474 | −$30,127,526 | The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two… |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 872308499)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2018-2019-Q4-920200 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $1,915,000 | FY2019 |
Other recipients funded under "SIF Stream3- Attraction" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2024-2025-Q4-820215 | IBM Canada Limited - IBM Canada Ltée | FY2025 | $210,000,000 | FY2025 |
| 033-2024-2025-Q3-514896 | Dow Chemical Canada ULC | FY2025 | $400,000,000 | FY2025 |
| 033-2024-2025-Q1-820057 | Aspect Biosystems Ltd. | FY2025 | $49,000,000 | FY2025 |
| 033-2024-2025-Q3-819849 | Ericsson Canada Inc. | FY2025 | $79,100,000 | FY2025 |
| 033-2024-2025-Q1-820155 | Heidelberg Materials Canada Limited | FY2025 | $49,000,000 | FY2025 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2020-2021-Q3-815733 · retrieved 2026-11-13.